Active Trials Closed for Recruitment

Active Trials listed below are clinical trials closed to recruitment but the study is ongoing in that participants are receiving an intervention or being examined. Please click on the links below for further information about trials currently closed for recruitment.

01.07 WBRTMel
01.09 RTN2
01.12 EAGLE FM
03.12 MelMarT Pilot
04.17 SMARTI
01.15 CHARLI
02.12 RADICAL

01.07 WBRTMel

Whole Brain Radiotherapy following local treatment of intracranial metastases of melanoma – A randomised Phase III trial

Chair

Professor Gerald Fogarty

Registration ID

ACTRN12607000512426

Trial Status

Active Trial Closed for Recruitment

MASC Trials Contact

wbrt@masc.org.au

01.09 RTN2

A randomised trial of post-operative radiation therapy following wide excision of neurotropic melanoma of the head and neck

Chair

Associate Professor Matthew Foote

Registration ID

ACTRN12610000478011

Trial Status

Active Trial Closed for Recruitment

MASC Trials Contact

rtn2@masc.org.au

01.12 EAGLE FM

Evaluation of groin lymphadenectomy extent for metastatic melanoma - A randomised phase III trial to evaluate survival, morbidity, and quality of life

Chair

Professor Andrew Spillane

Registration ID

ACTRN12614000721606

Trial Status

Active Trial Closed for Recruitment

MASC Trials Contact

eaglefm@masc.org.au

03.12 MelMarT Pilot

A Phase III, multi-centre, multi-national randomised control trial investigating 1cm vs 2cm excision margins for primary cutaneous melanoma

Chair

Professor Michael Henderson and Professor Mark Moncrieff

Registration ID

ACTRN12614000667617

Trial Status

Active Trial Closed for Recruitment

MASC Trials Contact

melmart@masc.org.au

04.17 SMARTI

A Pilot Study of an Artificial Intelligence System as a Diagnostic Aide for Better Skin Cancer Management

Chair

Associate Professor Victoria Mar

Registration ID

NCT04040114

Trial Status

Active Trial Closed for Recruitment

MASC Trials Contact

smarti@masc.org.au

01.15 CHARLI

A Phase Ib/II Trial of Ipilimumab-Nivolumab-Denosumab and Nivolumab-Denosumab in Patients with Unresectable Stage III and IV Melanoma

Chair

Associate Professor Shahneen Sandhu

Registration ID

ACTRN12617000772347

Trial Status

Active Trial Closed for Recruitment

MASC Trials Contact

charli@masc.org.au

02.12 RADICAL

A randomised controlled multicentre trial of imiquimod versus radiotherapy for lentigo maligna when staged surgical excision with 5mm margins is not possible, is refused, or fails

Chair

Associate Professor Pascale Guitera

Registration ID

ACTRN12615000266561

Trial Status

Active Trial Closed for Recruitment

MASC Trials Contact

radical@masc.org.au